| Literature DB >> 23960074 |
Huafei Zou1, Yumei Lai, Xuwen Zhao, Gonghong Yan, Dongzhu Ma, Nayra Cardenes, Sruti Shiva, Yongjian Liu, Xiaochun Bai, Yong Jiang, Yu Jiang.
Abstract
Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth and metabolism. Its activity is controlled by various types of signals, including growth factors, nutrients, and stresses. In this study, we show that changes in expression levels of two antiapoptotic proteins, Bcl-2 and Bcl-XL, also affect mTORC1 signaling activity. In cells overexpressing Bcl-XL, mTORC1 activity is increased and becomes less sensitive to growth factor or nutrient conditions. In contrast, reduction in expression levels of the two antiapoptotic proteins inhibits mTORC1 signaling activity. Our results suggest that the effect of Bcl-2 and Bcl-XL on mTORC1 is mediated by FKBP38, an inhibitor of mTORC1. The two proteins compete with mTORC1 for FKBP38 binding and hence alter mTORC1 activity. This study reveals a novel cross-talk between Bcl-2/XL and mTORC1 signaling, which is likely to contribute to cancer development.Entities:
Keywords: Bcl-2; Bcl-XL; FKBP38; Mitochondria; S6 Kinase; Signaling; mTOR Complex (mTORC); mTORC1
Mesh:
Substances:
Year: 2013 PMID: 23960074 PMCID: PMC3789978 DOI: 10.1074/jbc.M113.505370
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157